# Elicio Therapeutics, Inc.: Form 8-K, filed Jul 2, 2026

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: 8-K
- Filed: 2026-07-02
- Accepted by EDGAR: Jul 2, 2026, 06:20 ET
- Period: 2026-07-01
- Accession: 0001104659-26-080058
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000110465926080058/tm2619637d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000110465926080058/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000110465926080058/tm2619637d1_8k.htm

Filed Jul 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-080058. Last ingested by Listed: Nov 5, 2026, 17:56 ET. No prices; not investment advice.